NovoCure (NVCR) Receivables (2014 - 2026)
NovoCure recorded quarterly Receivables of $61.4 million in Q1 2026, down 7.64% quarter-over-quarter from $66.5 million in Q4 2025, and up 51.15% year-over-year from $40.6 million in Q1 2025.
NovoCure's Receivables history runs 13 years deep, the most recent figure standing at $61.4 million for Q1 2026.
- In Q1 2026, Receivables rose 51.15% year-over-year to $61.4 million; the TTM figure through Mar 2026 stood at $61.4 million (up 51.15% YoY), while the FY2025 annual figure was $66.5 million, up 62.93% from the prior year.
- Receivables came in at $61.4 million for Q1 2026 at NovoCure, down from $66.5 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $101.0 million in Q1 2022 to a low of $17.5 million in Q3 2022.
- A 5-year average of $59.4 million and a median of $65.1 million in 2023 frame the typical range for Receivables.
- Across the five-year window, Receivables soared 443.65% in 2022 and slumped 46.9% in 2024, its largest moves.
- NovoCure's Receivables stood at $28.2 million in 2022, then slipped by 4.34% to $26.9 million in 2023, then soared by 51.47% to $40.8 million in 2024, then surged by 62.93% to $66.5 million in 2025, then decreased by 7.64% to $61.4 million in 2026.
- According to Business Quant data, Receivables over the past three periods registered $61.4 million, $66.5 million, and $92.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 6.36 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 3.15 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 3.82 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1.11 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 1.09 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 61.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 61.38 Mn |
| Dec 31, 2025 | 66.46 Mn |
| Sep 30, 2025 | 92.48 Mn |
| Jun 30, 2025 | 46.09 Mn |
| Mar 31, 2025 | 40.61 Mn |
| Dec 31, 2024 | 40.79 Mn |
| Sep 30, 2024 | 72.80 Mn |
| Jun 30, 2024 | 37.69 Mn |
| Mar 31, 2024 | 69.78 Mn |
| Dec 31, 2023 | 26.93 Mn |
| Sep 30, 2023 | 65.13 Mn |
| Jun 30, 2023 | 70.99 Mn |
| Mar 31, 2023 | 74.83 Mn |
| Dec 31, 2022 | 28.15 Mn |
| Sep 30, 2022 | 17.48 Mn |
| Jun 30, 2022 | 97.56 Mn |
| Mar 31, 2022 | 100.97 Mn |
| Dec 31, 2021 | 17.03 Mn |
| Sep 30, 2021 | 17.60 Mn |
| Jun 30, 2021 | 17.95 Mn |
| Mar 31, 2021 | 18.92 Mn |
| Dec 31, 2020 | 21.25 Mn |
| Sep 30, 2020 | 84.56 Mn |
| Jun 30, 2020 | 38.10 Mn |
| Mar 31, 2020 | 65.14 Mn |
| Dec 31, 2019 | 29.20 Mn |
| Sep 30, 2019 | 17.92 Mn |
| Jun 30, 2019 | 42.53 Mn |
| Mar 31, 2019 | 39.22 Mn |
| Dec 31, 2018 | 14.28 Mn |
| Sep 30, 2018 | 35.39 Mn |
| Jun 30, 2018 | 37.64 Mn |
| Mar 31, 2018 | 9.94 Mn |
| Dec 31, 2017 | 8.11 Mn |
| Sep 30, 2017 | 5.56 Mn |
| Jun 30, 2017 | 13.89 Mn |
| Mar 31, 2017 | 11.83 Mn |
| Dec 31, 2016 | 10.08 Mn |
| Sep 30, 2016 | 11.84 Mn |
| Jun 30, 2016 | 12.53 Mn |
| Mar 31, 2016 | 11.34 Mn |
| Sep 30, 2015 | 10.16 Mn |
| Dec 31, 2014 | 5.71 Mn |